Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Du, Weia | Ma, Xueleia; * | Kong, Weiqib | Liu, Taoc | Wei, Benlingd | Yu, Jiayuna | Li, Yanyana | Huang, Jingwene | Li, Zikangc | Liu, Leia
Affiliations: [a] Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Sichuan, China | [b] West China School of Medicine, Sichuan University, Sichuan, China | [c] The Second Affiliated Hospital of Xuzhou Medical College China, Xuzhou, Jinagsu, China | [d] Yaan People Hospital, Sichuan, China | [e] West China Hospital, Sichuan University, Sichuan, China
Correspondence: [*] Corresponding author: Xuelei Ma, West China Hospital, No. 37 GuoXue Alley, Chengdu 610041, Sichuan, China. Tel.: +86 28 85423278; E-mail: drmaxuelei@gmail.com.
Abstract: Background:MicroRNAs (miRNAs) are small non-coding RNAs of 20–22 nucleotides in length, which regulate the translation or degradation of human messenger RNA (mRNA). MiRNAs involve in the regulation of most biological processes, as well as human diverse diseases including cancer. Recently, many studies investigated the association between miR-196a2 rs11614913 polymorphism and colorectal cancer (CRC), which showed inconclusive results. Methodology/Principal Findings:We conducted a meta-analysis of 6 studies that included 1800 cases and 2329 controls. There was a statistically decreased risk of CRC in dominant model, recessive model and homozygous model. In the Asian group, significantly decreased susceptibility of CRC was found in allele model, dominant model, recessive model and homozygous model. As for the Caucasian group, none of genetic models demonstrates significant association between miR-196a2 rs11614913 polymorphism and susceptibility of CRC. Conclusions:These findings supported that miR-196a2 rs11614913 polymorphism may contribute to the susceptibility of CRC.
Keywords: Colorectal cancer, miR-196a2, polymorphism
DOI: 10.3233/CBM-140389
Journal: Cancer Biomarkers, vol. 13, no. 6, pp. 457-464, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl